Abstract:Alz heimer’s disease (AD) continues to threaten aged individuals and health care systems around the world. Human beings have been trying to postpone, reduce, or eliminate the primary risk factor for AD, aging, throughout history. Despite this, there is currently only symptomatic treatment for AD and this treatment is limited to only a handful of FDA approved AD drugs.
“…We observed greater degree of % ROI colocalization of both C1q eat-me tag as well as PSD95 inside the astrocytic volume, in the hippocampal slices that were incubated with Aβ 42 peptide as compared to the control. This indicates an increased synaptic pruning activity in the presence of Aβ 42 oligomers which correlates with the previous studies in different Alzheimer’s models ( Sellgren et al., 2019 ; Brucato and Benjamin, 2020 ). The statistical analysis can be performed by common programs such as Graph Pad Prism or SPSS.…”
Section: Quantification and Statistical Analysissupporting
“…We observed greater degree of % ROI colocalization of both C1q eat-me tag as well as PSD95 inside the astrocytic volume, in the hippocampal slices that were incubated with Aβ 42 peptide as compared to the control. This indicates an increased synaptic pruning activity in the presence of Aβ 42 oligomers which correlates with the previous studies in different Alzheimer’s models ( Sellgren et al., 2019 ; Brucato and Benjamin, 2020 ). The statistical analysis can be performed by common programs such as Graph Pad Prism or SPSS.…”
Section: Quantification and Statistical Analysissupporting
“…These processes can be influenced by multiple factors, including OS and inflammation, which were already discussed, and novel processes like epigenetic control [271] .…”
Section: Neurodevelopment and Neurotransmission Associated Processesmentioning
confidence: 97%
“…Rather, it was demonstrated that the once “supporting” cells types present in SNC have an important role in the regulation of Brain processes, including neurotransmission and microenvironment homeostasis [165] , [166] . As briefly described in Box 2 , Microglia modulate synaptogenesis, synapse tagging and elimination or synaptic pruning, help repair damage from injury and modulate synaptic transmission through cytokines [281] and in particular through complement proteins release [271] , [282] .…”
Section: Neurodevelopment and Neurotransmission Associated Processesmentioning
“… Linnartz-Gerlach et al (2019) demonstrated that aged TREM2 knock-out mice had lower transcription of C1qa, C1qb, C1qc, C3, and C4b. Thus the reactivation of complement-mediated synaptic pruning is a distinct possibility in AD ( Stephan et al, 2012 ; Heppner et al, 2015 ; Brucato and Benjamin, 2020 ; Gomez-Arboledas et al, 2021 ), a scenario that has been also observed in human mutant APP mice (J20) ( Hong et al, 2016 ). Refer to Figure 3 which presents a basic mechanism linking LDAM and aberrant synaptic elimination by microglia which may be mediated by increased complement deposition.…”
Alzheimer’s disease (AD) is characterised by synaptic dysfunction accompanied by the microscopically visible accumulation of pathological protein deposits and cellular dystrophy involving both neurons and glia. Late-stage AD shows pronounced loss of synapses and neurons across several differentially affected brain regions. Recent studies of advanced AD using post-mortem brain samples have demonstrated the direct involvement of microglia in synaptic changes. Variants of the Apolipoprotein E and Triggering Receptors Expressed on Myeloid Cells gene represent important determinants of microglial activity but also of lipid metabolism in cells of the central nervous system. Here we review evidence that may help to explain how abnormal lipid metabolism, microglial activation, and synaptic pathophysiology are inter-related in AD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.